1. Home
  2. NVCR vs SEM Comparison

NVCR vs SEM Comparison

Compare NVCR & SEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • SEM
  • Stock Information
  • Founded
  • NVCR 2000
  • SEM 1996
  • Country
  • NVCR Switzerland
  • SEM United States
  • Employees
  • NVCR N/A
  • SEM N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • SEM Hospital/Nursing Management
  • Sector
  • NVCR Health Care
  • SEM Health Care
  • Exchange
  • NVCR Nasdaq
  • SEM Nasdaq
  • Market Cap
  • NVCR 1.9B
  • SEM 1.9B
  • IPO Year
  • NVCR 2015
  • SEM 2009
  • Fundamental
  • Price
  • NVCR $19.11
  • SEM $15.29
  • Analyst Decision
  • NVCR Buy
  • SEM Buy
  • Analyst Count
  • NVCR 6
  • SEM 4
  • Target Price
  • NVCR $32.83
  • SEM $27.33
  • AVG Volume (30 Days)
  • NVCR 941.3K
  • SEM 1.8M
  • Earning Date
  • NVCR 07-24-2025
  • SEM 05-01-2025
  • Dividend Yield
  • NVCR N/A
  • SEM 2.08%
  • EPS Growth
  • NVCR N/A
  • SEM N/A
  • EPS
  • NVCR N/A
  • SEM 1.37
  • Revenue
  • NVCR $621,711,000.00
  • SEM $5,219,066,000.00
  • Revenue This Year
  • NVCR $5.56
  • SEM $5.26
  • Revenue Next Year
  • NVCR $9.15
  • SEM $5.48
  • P/E Ratio
  • NVCR N/A
  • SEM $31.50
  • Revenue Growth
  • NVCR 18.27
  • SEM 16.44
  • 52 Week Low
  • NVCR $14.17
  • SEM $14.03
  • 52 Week High
  • NVCR $34.13
  • SEM $40.98
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 58.46
  • SEM 48.73
  • Support Level
  • NVCR $18.66
  • SEM $14.27
  • Resistance Level
  • NVCR $20.06
  • SEM $15.42
  • Average True Range (ATR)
  • NVCR 0.86
  • SEM 0.40
  • MACD
  • NVCR 0.19
  • SEM 0.07
  • Stochastic Oscillator
  • NVCR 71.98
  • SEM 82.41

About NVCR NovoCure Limited

NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About SEM Select Medical Holdings Corporation

Select Medical Holdings Corp is a healthcare company that operates through three segments: critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics. Critical illness recovery hospitals which derives maximum revenue consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. The rehabilitation hospital segment consists of hospitals designed to serve patients that require intensive physical rehabilitation care. Patients are typically admitted to critical illness recovery hospitals and rehabilitation hospitals from general acute care hospitals. The outpatient rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services.

Share on Social Networks: